0001012975-16-001084.txt : 20160314
0001012975-16-001084.hdr.sgml : 20160314
20160314160957
ACCESSION NUMBER: 0001012975-16-001084
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20160314
DATE AS OF CHANGE: 20160314
EFFECTIVENESS DATE: 20160314
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Centrexion Therapeutics Corp
CENTRAL INDEX KEY: 0001592052
IRS NUMBER: 320402377
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-259218
FILM NUMBER: 161503923
BUSINESS ADDRESS:
STREET 1: 509 S. EXETER ST., SUITE 202
CITY: BALTIMORE
STATE: MD
ZIP: 21202
BUSINESS PHONE: 212-956-1111
MAIL ADDRESS:
STREET 1: 509 S. EXETER ST., SUITE 202
CITY: BALTIMORE
STATE: MD
ZIP: 21202
FORMER COMPANY:
FORMER CONFORMED NAME: Centrexion Corp
DATE OF NAME CHANGE: 20131114
D
1
primary_doc.xml
X0707
D
LIVE
0001592052
Centrexion Therapeutics Corp
509 S. EXETER ST., SUITE 202
BALTIMORE
MD
MARYLAND
21202
410-522-8701
DELAWARE
Centrexion Corp
Corporation
true
2013
Sol
Barer
c/o Centrexion Corporation
509 S. Exeter St., Suite 202
Baltimore
MD
MARYLAND
21202
Director
Isaac
Blech
c/o Centrexion Corporation
509 S. Exeter St., Suite 202
Baltimore
MD
MARYLAND
21202
Director
Kerrie
L.
Brady
c/o Centrexion Corporation
509 S. Exeter St., Suite 202
Baltimore
MD
MARYLAND
21202
Executive Officer
James
N.
Campbell
c/o Centrexion Corporation
509 S. Exeter St., Suite 202
Baltimore
MD
MARYLAND
21202
Executive Officer
Director
Jeffrey
B.
Kindler
c/o Centrexion Corporation
509 S. Exeter St., Suite 202
Baltimore
MD
MARYLAND
21202
Executive Officer
Arnold
L.
Oronsky
c/o Centrexion Corporation
509 S. Exeter St., Suite 202
Baltimore
MD
MARYLAND
21202
Director
Gregg
Beloff
c/o Centrexion Corporation
509 S. Exeter St., Suite 202
Baltimore
MD
MARYLAND
21202
Executive Officer
Shengda
Zan
c/o Centrexion Corporation
509 S. Exeter St., Suite 202
Baltimore
MD
MARYLAND
21202
Director
Biotechnology
Decline to Disclose
- 06b
false
2016-03-01
false
true
Convertible notes and associated warrants
false
0
N/A
None
Maxim Group LLC
120708
405 Lexington Avenue
New York
NY
NEW YORK
10174
All States
false
Indefinite
10516500
Indefinite
The notes are convertible upon certain qualified financings at a price per share that is variable depending on the price per share paid in such financing.
false
25
537990
0
0
true
false
Centrexion Therapeutics Corp
/s/ Kerrie Brady
Kerrie Brady
Authorized Person
2016-03-14